Literature DB >> 10666667

The Down syndrome critical region.

B L Shapiro1.   

Abstract

Since the early 1970's numerous attempts have been made to learn whether specific segments of chromosome 21, when triplicated, are responsible for the clinical condition Down syndrome (DS). Studies were reported in which positive or negative clinical diagnoses of DS were made in the presence of partial trisomy of one or another segment of the chromosome. The distal half of the long arm of 21 (21q22) possesses most of the gene transcribing sites of the chromosome. It was this region that was thought to contain loci essential to production of the clinical syndrome. Subsequent studies identified subregions of this band as "minimal" or "critical" sites necessary and sufficient to produce the clinical condition. A major problem with these assignments was that different investigators defined different critical/minimal regions. In 1994 evidence was presented in which regions of most of the long arm of chromosome 21 were said to contribute to the DS phenotype. Soon after, a report described a child with DS and partial tetrasomy of the short arm and proximal long arm of 21, segments clearly distinct from the previously identified critical areas. Thus the clinical diagnosis of DS can be made in the presence of partial aneuploidy of nearly all segments of chromosome 21. It must be concluded that no evidence exists that individual loci on 21 are singularly responsible for specific phenotypic abnormalities in DS. Without exception, each of the clinical findings associated with DS is a multifactorial trait. The analysis of each trait in DS should thus be similar to analyses of the same traits in the general population with a focus on the way aneuploidy affects expression of multifactorial characteristics.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10666667     DOI: 10.1007/978-3-7091-6380-1_3

Source DB:  PubMed          Journal:  J Neural Transm Suppl        ISSN: 0303-6995


  17 in total

1.  Comparative analysis of the DYRK1A-SRSF6-TNNT2 pathway in myocardial tissue from individuals with and without Down syndrome.

Authors:  Adolfo Quiñones-Lombraña; Javier G Blanco
Journal:  Exp Mol Pathol       Date:  2019-06-12       Impact factor: 3.362

Review 2.  Disturbance of redox homeostasis in Down Syndrome: Role of iron dysmetabolism.

Authors:  Eugenio Barone; Andrea Arena; Elizabeth Head; D Allan Butterfield; Marzia Perluigi
Journal:  Free Radic Biol Med       Date:  2017-07-10       Impact factor: 7.376

3.  Trisomy-driven overexpression of DYRK1A kinase in the brain of subjects with Down syndrome.

Authors:  Wieslaw K Dowjat; Tatyana Adayev; Izabela Kuchna; Krzysztof Nowicki; Sonia Palminiello; Yu Wen Hwang; Jerzy Wegiel
Journal:  Neurosci Lett       Date:  2006-12-04       Impact factor: 3.046

Review 4.  Mouse chromosome engineering for modeling human disease.

Authors:  Louise van der Weyden; Allan Bradley
Journal:  Annu Rev Genomics Hum Genet       Date:  2006       Impact factor: 8.929

5.  DYRK1A haploinsufficiency causes a new recognizable syndrome with microcephaly, intellectual disability, speech impairment, and distinct facies.

Authors:  Jianling Ji; Hane Lee; Bob Argiropoulos; Naghmeh Dorrani; John Mann; Julian A Martinez-Agosto; Natalia Gomez-Ospina; Natalie Gallant; Jonathan A Bernstein; Louanne Hudgins; Leah Slattery; Bertrand Isidor; Cédric Le Caignec; Albert David; Ewa Obersztyn; Barbara Wiśniowiecka-Kowalnik; Michelle Fox; Joshua L Deignan; Eric Vilain; Emily Hendricks; Margaret Horton Harr; Sarah E Noon; Jessi R Jackson; Alisha Wilkens; Ghayda Mirzaa; Noriko Salamon; Jeff Abramson; Elaine H Zackai; Ian Krantz; A Micheil Innes; Stanley F Nelson; Wayne W Grody; Fabiola Quintero-Rivera
Journal:  Eur J Hum Genet       Date:  2015-05-06       Impact factor: 4.246

Review 6.  Rare variants and the oligogenic architecture of autism.

Authors:  Tianyun Wang; Peiyao A Zhao; Evan E Eichler
Journal:  Trends Genet       Date:  2022-04-09       Impact factor: 11.821

Review 7.  Mechanisms of tau-induced neurodegeneration.

Authors:  Khalid Iqbal; Fei Liu; Cheng-Xin Gong; Alejandra Del C Alonso; Inge Grundke-Iqbal
Journal:  Acta Neuropathol       Date:  2009-01-30       Impact factor: 17.088

8.  Decrease of protein phosphatase 2A and its association with accumulation and hyperphosphorylation of tau in Down syndrome.

Authors:  Zhihou Liang; Fei Liu; Khalid Iqbal; Inge Grundke-Iqbal; Jerzy Wegiel; Cheng-Xin Gong
Journal:  J Alzheimers Dis       Date:  2008-04       Impact factor: 4.472

9.  Molecular and comparative genetics of mental retardation.

Authors:  Jennifer K Inlow; Linda L Restifo
Journal:  Genetics       Date:  2004-02       Impact factor: 4.562

10.  Cell type-specific over-expression of chromosome 21 genes in fibroblasts and fetal hearts with trisomy 21.

Authors:  Chi-Ming Li; Meirong Guo; Martha Salas; Nicole Schupf; Wayne Silverman; Warren B Zigman; Sameera Husain; Dorothy Warburton; Harshwardhan Thaker; Benjamin Tycko
Journal:  BMC Med Genet       Date:  2006-03-15       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.